» Articles » PMID: 25220354

Circulating MiRNAs: Roles in Cancer Diagnosis, Prognosis and Therapy

Overview
Specialty Pharmacology
Date 2014 Sep 16
PMID 25220354
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) belong to a class of small non-coding RNAs that regulate numerous biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have been detected in remarkably stable forms in many types of body fluids. A comparison between cancer patients and healthy individuals has clearly shown that certain types of circulating miRNAs are associated with cancer initiation and progression. Research on miRNA-based biomarkers has witnessed phenomenal growth, owing to the non-invasive nature of miRNA-based screening assays and their sensitivity and specificity in detecting cancers. Consequently, a considerable effort has been devoted to identify suitable miRNAs for cancer diagnosis and also decode the information carried by circulating miRNAs. This review highlights the current studies that focus on the identification of circulating miRNA-based diagnostic and prognostic markers, for the most prevalent types of cancer. Additionally, the review also provides an insight into the putative functions of miRNAs, and attempts to delineate the mechanisms through which they are released into the bloodstream. Moreover, methodologies and strategies for identification of circulating miRNAs in cancers are summarized. Finally, potential strategies for circulating miRNA-based cancer therapies are proposed.

Citing Articles

Novel miRNA markers and their mechanism of esophageal squamous cell carcinoma (ESCC) based on TCGA.

Yuan P, Gao X, Xu M, Qiu L, Xiong Z, Shen J Sci Rep. 2024; 14(1):27261.

PMID: 39516222 PMC: 11549395. DOI: 10.1038/s41598-024-76321-0.


An ultra-sensitive suboptimal protospacer adjacent motif enhanced rolling circle amplification assay based on CRISPR/Cas12a for detection of miR-183.

Lu Z, Wang S, Li P, Yang H, Han S, Zhang S Front Bioeng Biotechnol. 2024; 12:1444908.

PMID: 39359259 PMC: 11445046. DOI: 10.3389/fbioe.2024.1444908.


Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer.

Kazlauskiene M, Klimaite R, Kondrotiene A, Dauksa A, Dauksiene D, Verkauskiene R Int J Mol Sci. 2024; 25(15).

PMID: 39125979 PMC: 11313006. DOI: 10.3390/ijms25158412.


Exposure to per- and polyfluoroalkyl substances and alterations in plasma microRNA profiles in children.

Li Y, Baumert B, Stratakis N, Goodrich J, Wu H, Liu S Environ Res. 2024; 259:119496.

PMID: 38936497 PMC: 11847561. DOI: 10.1016/j.envres.2024.119496.


The role of miRNAs as biomarkers in breast cancer.

Baylie T, Kasaw M, Getinet M, Getie G, Jemal M, Nigatu A Front Oncol. 2024; 14:1374821.

PMID: 38812786 PMC: 11133523. DOI: 10.3389/fonc.2024.1374821.